○Eri Takeuchi¹, Yasumasa Hashimoto¹, Michihiro Imamura¹, Takefumi Kikusui², Masayuki Sekiguchi^1,3, Yoshitsugu Aoki¹ (1. Department of Molecular Therapy National Institute of Neuroscience, National Center of Neurology and Psychiatry, 2. School of Veterinary Medicine, Azabu University, 3. Laboratory of Pharmacology, Faculty of Pharmaceutical Science, Tokyo University of Science)

○Yuki MORIYA^1,2, Yoshiyuki Kasahara^2,3,4, Masafumi Shimada², Yasufumi Sakakibara^2,5, Hideaki Fujii⁸, Hiroshi Nagase⁶, Soichiro Ide¹, Kazutaka Ikeda¹, Frank Scott Hall⁷, George R Uhl⁹, Ichiro Sora^10,2 (1. Tokyo Metropolitan Institute of Medical Science, 2. Department of Biological Psychiatry, Tohoku University Graduate School of Medicine, 3. Department of Maternal and Fetal Therapeutics, Tohoku University Graduate School of Medicine, 4. Department of Maternal and Child Healthcare Medical Science, Tohoku University Graduate School of Medicine, 5. Department of Neurogenetics, Center for Development of Advanced Medicine for Dementia, National Center for Geriatrics and Gerontology, 6. International Institute for Integrative Sleep Medicine (WPI-IIIS), University of Tsukuba, 7. Department of Pharmacology and Experimental Therapeutics, College of Pharmacy and Pharmaceutical Sciences, University of Toledo, Toledo, OH, USA, 8. Laboratory of Medicinal Chemistry, School of Pharmacy, Kitasato University, 9. Departments of Neurology and Pharmacology, University of Maryland School of Medicine, and VA Maryland Healthcare System, Baltimore, MD, USA, 10. Department of Psychiatry, Kobe University Graduate School of Medicine)